Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03077672 · ClinicalTrials.gov registry record
Mitochondrial DNA as a Biomarker of Sepsis Severity
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 1,304
- Enrollment target
NCT03077672 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 1,304 participants.
The verdict
NCT03077672 has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 1,304 participants
- Enrollment target
Study Summary
Mitochondria are organelles (a specialized subunit of a cell) responsible for providing cells with energy. For reasons not yet understood, mitochondria will release their DNA into blood in response to cellular injury or cell death. With a simple blood draw, investigators can measure the amount of mitochondrial DNA in a patient's blood. The investigators' hypothesis, is that mitochondrial DNA can be used as a surrogate marker of cellular injury to predict patient outcomes. The investigators intend to test their hypothesis by measuring mitochondrial DNA in adult patients presenting to the Emergency Department with sepsis (a life-threatening condition due to an infection) and observing their hospital course.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,304 participants |
| Start Date | 2017-02-10 |
| Est. Completion | 2020-12-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03077672
The ClinicalTrials.gov registry entry for NCT03077672 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,304 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03077672 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03077672 about?
NCT03077672 is a clinical study titled "Mitochondrial DNA as a Biomarker of Sepsis Severity". Mitochondria are organelles (a specialized subunit of a cell) responsible for providing cells with energy. For reasons not yet understood, mitochondria will release their DNA into blood in response to cellular injury or cell death. With a simple blood draw, investigators can measure the amount of m...
What is the current status of trial NCT03077672?
This trial is currently completed. The enrollment target is 1,304 participants. The study started on 2017-02-10. Estimated completion is 2020-12-22.
Who is sponsoring clinical trial NCT03077672?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.